Massivemarkets

SEC Form 4

Braveheart Bio, Inc. (BRVE) insider trading

In the 12 months to Nov 19, 2026, 12 BRVE insiders reported open-market purchases of $159.0M across 12 filings; no open-market sales were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$0
0 filings · 0 insiders
Open-market purchases
$159.0M
12 filings

Who traded BRVE, and when

  • Purchase

BRVE daily close from Aug 6, 2026 to Nov 18, 2026, between $17.42 and $30.00, last $18.53. 0 sale and 12 purchase filings by 12 insiders, marked at their filing dates. Erez Chimovits, Director: bought $34.9M across 1 filing, first filed Aug 11, 2026, last Aug 11, 2026. Forbion Ventures VII Management B.V., 10% owner: bought $34.6M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. Forbion Growth III Management B.V., 10% owner: bought $30.2M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. ORBIMED ADVISORS LLC, Director: bought $30.0M across 1 filing, first filed Aug 11, 2026, last Aug 11, 2026. Benjamin A. Horowitz, 10% owner: bought $19.8M across 1 filing, first filed Aug 11, 2026, last Aug 11, 2026. OrbiMed Capital GP IX LLC, Director: bought $4.9M across 1 filing, first filed Aug 11, 2026, last Aug 11, 2026. Christopher Viehbacher, Director: bought $1.5M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. Travis Murdoch, CEO and President: bought $1.5M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. David Charles Lubner, Director: bought $1.0M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. James Paul Rickey, Chief Financial Officer: bought $500.0K across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. David I. Malek, Director: bought $75.0K across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. Michele A. Anderson, Chief Development Officer: bought $20.0K across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026.

Largest mark · tap a row for others

Erez Chimovits · Director

Purchase $34,920,000

1,940,000 shares at $18.00 avg

Filed Aug 11, 2026 · traded Aug 7

Close on filing date $25.01

BRVE daily closelast $18.53

Erez Chimovits · Director

$34.9M bought

Forbion Ventures VII Management B.V. · 10% owner

$34.6M bought

Forbion Growth III Management B.V. · 10% owner

$30.2M bought

ORBIMED ADVISORS LLC · Director

$30.0M bought

Benjamin A. Horowitz · 10% owner

$19.8M bought

OrbiMed Capital GP IX LLC · Director

$4.9M bought

Christopher Viehbacher · Director

$1.5M bought

Travis Murdoch · CEO and President

$1.5M bought

David Charles Lubner · Director

$1.0M bought

James Paul Rickey · Chief Financial Officer

$500.0K bought

David I. Malek · Director

$75.0K bought

Michele A. Anderson · Chief Development Officer

$20.0K bought
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

12 filings in the last 12 months
Other insider activity (not market trades) · 6 records
  • Other6 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once
When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

Has Braveheart Bio, Inc.'s CEO sold stock?

No. Travis Murdoch (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is BRVE’s insider data?

These are BRVE Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track BRVE insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for BRVE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.